Cargando…

Does Anticoagulant Medication Alter Fracture-Healing? A Morphological and Biomechanical Evaluation of the Possible Effects of Rivaroxaban and Enoxaparin Using a Rat Closed Fracture Model

Low molecular weight heparin (LMWH) is routinely used to prevent thromboembolism in orthopaedic surgery, especially in the treatment of fractures or after joint-replacement. Impairment of fracture-healing due to increased bone-desorption, delayed remodelling and lower calcification caused by direct...

Descripción completa

Detalles Bibliográficos
Autores principales: Prodinger, Peter Michael, Burgkart, Rainer, Kreutzer, Kilian, Liska, Franz, Pilge, Hakan, Schmitt, Andreas, Knödler, Martina, Holzapfel, Boris Michael, Hapfelmeier, Alexander, Tischer, Thomas, Bissinger, Oliver
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4959754/
https://www.ncbi.nlm.nih.gov/pubmed/27455072
http://dx.doi.org/10.1371/journal.pone.0159669
_version_ 1782444442358120448
author Prodinger, Peter Michael
Burgkart, Rainer
Kreutzer, Kilian
Liska, Franz
Pilge, Hakan
Schmitt, Andreas
Knödler, Martina
Holzapfel, Boris Michael
Hapfelmeier, Alexander
Tischer, Thomas
Bissinger, Oliver
author_facet Prodinger, Peter Michael
Burgkart, Rainer
Kreutzer, Kilian
Liska, Franz
Pilge, Hakan
Schmitt, Andreas
Knödler, Martina
Holzapfel, Boris Michael
Hapfelmeier, Alexander
Tischer, Thomas
Bissinger, Oliver
author_sort Prodinger, Peter Michael
collection PubMed
description Low molecular weight heparin (LMWH) is routinely used to prevent thromboembolism in orthopaedic surgery, especially in the treatment of fractures or after joint-replacement. Impairment of fracture-healing due to increased bone-desorption, delayed remodelling and lower calcification caused by direct osteoclast stimulation is a well-known side effect of unfractioned heparin. However, the effect of LMWH is unclear and controversial. Recent studies strongly suggest impairment of bone-healing in-vitro and in animal models, characterized by a significant decrease in volume and quality of new-formed callus. Since October 2008, Rivaroxaban (Xarelto) is available for prophylactic use in elective knee- and hip-arthroplasty. Recently, some evidence has been found indicating an in vitro dose independent reduction of osteoblast function after Rivaroxaban treatment. In this study, the possible influence of Rivaroxaban and Enoxaparin on bone-healing in vivo was studied using a standardized, closed rodent fracture-model. 70 male Wistar-rats were randomized to Rivaroxaban, Enoxaparin or control groups. After pinning the right femur, a closed, transverse fracture was produced. 21 days later, the animals were sacrificed and both femora harvested. Analysis was done by biomechanical testing (three-point bending) and micro CT. Both investigated substances showed histomorphometric alterations of the newly formed callus assessed by micro CT analysis. In detail the bone (callus) volume was enhanced (sign. for Rivaroxaban) and the density reduced. The bone mineral content was enhanced accordingly (sign. for Rivaroxaban). Trabecular thickness was reduced (sign. for Rivaroxaban). Furthermore, both drugs showed significant enlarged bone (callus) surface and degree of anisotropy. In contrast, the biomechanical properties of the treated bones were equal to controls. To summarize, the morphological alterations of the fracture-callus did not result in functionally relevant deficits.
format Online
Article
Text
id pubmed-4959754
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-49597542016-08-08 Does Anticoagulant Medication Alter Fracture-Healing? A Morphological and Biomechanical Evaluation of the Possible Effects of Rivaroxaban and Enoxaparin Using a Rat Closed Fracture Model Prodinger, Peter Michael Burgkart, Rainer Kreutzer, Kilian Liska, Franz Pilge, Hakan Schmitt, Andreas Knödler, Martina Holzapfel, Boris Michael Hapfelmeier, Alexander Tischer, Thomas Bissinger, Oliver PLoS One Research Article Low molecular weight heparin (LMWH) is routinely used to prevent thromboembolism in orthopaedic surgery, especially in the treatment of fractures or after joint-replacement. Impairment of fracture-healing due to increased bone-desorption, delayed remodelling and lower calcification caused by direct osteoclast stimulation is a well-known side effect of unfractioned heparin. However, the effect of LMWH is unclear and controversial. Recent studies strongly suggest impairment of bone-healing in-vitro and in animal models, characterized by a significant decrease in volume and quality of new-formed callus. Since October 2008, Rivaroxaban (Xarelto) is available for prophylactic use in elective knee- and hip-arthroplasty. Recently, some evidence has been found indicating an in vitro dose independent reduction of osteoblast function after Rivaroxaban treatment. In this study, the possible influence of Rivaroxaban and Enoxaparin on bone-healing in vivo was studied using a standardized, closed rodent fracture-model. 70 male Wistar-rats were randomized to Rivaroxaban, Enoxaparin or control groups. After pinning the right femur, a closed, transverse fracture was produced. 21 days later, the animals were sacrificed and both femora harvested. Analysis was done by biomechanical testing (three-point bending) and micro CT. Both investigated substances showed histomorphometric alterations of the newly formed callus assessed by micro CT analysis. In detail the bone (callus) volume was enhanced (sign. for Rivaroxaban) and the density reduced. The bone mineral content was enhanced accordingly (sign. for Rivaroxaban). Trabecular thickness was reduced (sign. for Rivaroxaban). Furthermore, both drugs showed significant enlarged bone (callus) surface and degree of anisotropy. In contrast, the biomechanical properties of the treated bones were equal to controls. To summarize, the morphological alterations of the fracture-callus did not result in functionally relevant deficits. Public Library of Science 2016-07-25 /pmc/articles/PMC4959754/ /pubmed/27455072 http://dx.doi.org/10.1371/journal.pone.0159669 Text en © 2016 Prodinger et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Prodinger, Peter Michael
Burgkart, Rainer
Kreutzer, Kilian
Liska, Franz
Pilge, Hakan
Schmitt, Andreas
Knödler, Martina
Holzapfel, Boris Michael
Hapfelmeier, Alexander
Tischer, Thomas
Bissinger, Oliver
Does Anticoagulant Medication Alter Fracture-Healing? A Morphological and Biomechanical Evaluation of the Possible Effects of Rivaroxaban and Enoxaparin Using a Rat Closed Fracture Model
title Does Anticoagulant Medication Alter Fracture-Healing? A Morphological and Biomechanical Evaluation of the Possible Effects of Rivaroxaban and Enoxaparin Using a Rat Closed Fracture Model
title_full Does Anticoagulant Medication Alter Fracture-Healing? A Morphological and Biomechanical Evaluation of the Possible Effects of Rivaroxaban and Enoxaparin Using a Rat Closed Fracture Model
title_fullStr Does Anticoagulant Medication Alter Fracture-Healing? A Morphological and Biomechanical Evaluation of the Possible Effects of Rivaroxaban and Enoxaparin Using a Rat Closed Fracture Model
title_full_unstemmed Does Anticoagulant Medication Alter Fracture-Healing? A Morphological and Biomechanical Evaluation of the Possible Effects of Rivaroxaban and Enoxaparin Using a Rat Closed Fracture Model
title_short Does Anticoagulant Medication Alter Fracture-Healing? A Morphological and Biomechanical Evaluation of the Possible Effects of Rivaroxaban and Enoxaparin Using a Rat Closed Fracture Model
title_sort does anticoagulant medication alter fracture-healing? a morphological and biomechanical evaluation of the possible effects of rivaroxaban and enoxaparin using a rat closed fracture model
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4959754/
https://www.ncbi.nlm.nih.gov/pubmed/27455072
http://dx.doi.org/10.1371/journal.pone.0159669
work_keys_str_mv AT prodingerpetermichael doesanticoagulantmedicationalterfracturehealingamorphologicalandbiomechanicalevaluationofthepossibleeffectsofrivaroxabanandenoxaparinusingaratclosedfracturemodel
AT burgkartrainer doesanticoagulantmedicationalterfracturehealingamorphologicalandbiomechanicalevaluationofthepossibleeffectsofrivaroxabanandenoxaparinusingaratclosedfracturemodel
AT kreutzerkilian doesanticoagulantmedicationalterfracturehealingamorphologicalandbiomechanicalevaluationofthepossibleeffectsofrivaroxabanandenoxaparinusingaratclosedfracturemodel
AT liskafranz doesanticoagulantmedicationalterfracturehealingamorphologicalandbiomechanicalevaluationofthepossibleeffectsofrivaroxabanandenoxaparinusingaratclosedfracturemodel
AT pilgehakan doesanticoagulantmedicationalterfracturehealingamorphologicalandbiomechanicalevaluationofthepossibleeffectsofrivaroxabanandenoxaparinusingaratclosedfracturemodel
AT schmittandreas doesanticoagulantmedicationalterfracturehealingamorphologicalandbiomechanicalevaluationofthepossibleeffectsofrivaroxabanandenoxaparinusingaratclosedfracturemodel
AT knodlermartina doesanticoagulantmedicationalterfracturehealingamorphologicalandbiomechanicalevaluationofthepossibleeffectsofrivaroxabanandenoxaparinusingaratclosedfracturemodel
AT holzapfelborismichael doesanticoagulantmedicationalterfracturehealingamorphologicalandbiomechanicalevaluationofthepossibleeffectsofrivaroxabanandenoxaparinusingaratclosedfracturemodel
AT hapfelmeieralexander doesanticoagulantmedicationalterfracturehealingamorphologicalandbiomechanicalevaluationofthepossibleeffectsofrivaroxabanandenoxaparinusingaratclosedfracturemodel
AT tischerthomas doesanticoagulantmedicationalterfracturehealingamorphologicalandbiomechanicalevaluationofthepossibleeffectsofrivaroxabanandenoxaparinusingaratclosedfracturemodel
AT bissingeroliver doesanticoagulantmedicationalterfracturehealingamorphologicalandbiomechanicalevaluationofthepossibleeffectsofrivaroxabanandenoxaparinusingaratclosedfracturemodel